Beaten-down quality

Return on capital and balance-sheet strength intact; the price is not. Driven by the governed run of Quality compounders; the backtest is attached below.

follow · Plusdigest · Unlimited

followdigest · Unlimited

followweekly digest on

All92New entrantsBacktest

Rank	Ticker	Company	Verdict	Value against price	One year
1	NKE	Nike · $58.6B	Undervalued24%	$51.90 value · $39.48 price	−41.3%
2	UNH	UnitedHealth · $292B	Undervalued22%	$412.00 value · $321.40 price	−36.2%
3	CMCSA	Comcast · $95.8B	Undervalued30%	$38.60 value · $27.01 price	−28.1%
			Seriously undervalued
			Seriously undervalued
			Fairly valued

FreeThe top three are public; a free account sees ten and the weekly count of new names.Create a free account

Rank	Ticker	Company	Verdict	Value against price	One year
			Undervalued

FreeThe New Entrants tab is on Plus: what qualified since the last snapshot, by name.Create a free account

Win rate61%trailing twelve months, thirty-day holds

Average return per hold+7.4%thirty-day holds

StrategyQuality compoundersgoverned run

Point-in-time data, deflated Sharpe against the number of trials, out-of-sample embargo. The Quant lens on Track record shows the trial ledger. Past performance does not guarantee future results.

All92New entrants+12Backtest

+12 new since your last visit; the New Entrants tab names them on Plus.

Rank	Ticker	Company	Verdict	Value against price	One year
1	NKE	Nike · $58.6B	Undervalued24%	$51.90 value · $39.48 price	−41.3%
2	UNH	UnitedHealth · $292B	Undervalued22%	$412.00 value · $321.40 price	−36.2%
3	CMCSA	Comcast · $95.8B	Undervalued30%	$38.60 value · $27.01 price	−28.1%
4	PYPL	PayPal Holdings · $74.2B	Seriously undervalued39%	$118.00 value · $72.50 price	+8.4%
5	INTU	Intuit · $97.6B	Seriously undervalued37%	$563.00 value · $357.20 price	−12.9%
			Fairly valued

PlusThe full list with Follow and New Entrants is on Plus.See plans

Rank	Ticker	Company	Verdict	Value against price	One year
			Undervalued

PlusThe New Entrants tab is on Plus: what qualified since the last snapshot, by name.See plans

Win rate61%trailing twelve months, thirty-day holds

Average return per hold+7.4%thirty-day holds

StrategyQuality compoundersgoverned run

Point-in-time data, deflated Sharpe against the number of trials, out-of-sample embargo. The Quant lens on Track record shows the trial ledger. Past performance does not guarantee future results.

All92New entrants+12Backtest

Rank	Ticker	Company	Verdict	Value against price	One year
1	NKE	Nike · $58.6B	Undervalued24%	$51.90 value · $39.48 price	−41.3%
2	UNHnew	UnitedHealth · $292B	Undervalued22%	$412.00 value · $321.40 price	−36.2%
3	CMCSA	Comcast · $95.8B	Undervalued30%	$38.60 value · $27.01 price	−28.1%
4	PYPL	PayPal Holdings · $74.2B	Seriously undervalued39%	$118.00 value · $72.50 price	+8.4%
5	INTU	Intuit · $97.6B	Seriously undervalued37%	$563.00 value · $357.20 price	−12.9%
6	LMT	Lockheed Martin · $110B	Fairly valued7%	$502.00 value · $468.20 price	−14.2%

86 more names qualify on tonight’s snapshot.

Rank	Ticker	Company	Verdict	Value against price	One year
1	UNHnew	UnitedHealth · $292B	Undervalued22%	$412.00 value · $321.40 price	−36.2%

Names that qualified since the last snapshot. A followed list puts them in Monday’s letter.

No new entrants since the last visit.Tonight's snapshot ranked the same names as the last one.

Win rate61%trailing twelve months, thirty-day holds

Average return per hold+7.4%thirty-day holds

StrategyQuality compoundersgoverned run

Point-in-time data, deflated Sharpe against the number of trials, out-of-sample embargo. The Quant lens on Track record shows the trial ledger. Past performance does not guarantee future results.

All92New entrants+12Backtest

Rank	Ticker	Company	Verdict	Value against price	One year
1	NKE	Nike · $58.6B	Undervalued24%	$51.90 value · $39.48 price	−41.3%
2	UNHnew	UnitedHealth · $292B	Undervalued22%	$412.00 value · $321.40 price	−36.2%
3	CMCSA	Comcast · $95.8B	Undervalued30%	$38.60 value · $27.01 price	−28.1%
4	PYPL	PayPal Holdings · $74.2B	Seriously undervalued39%	$118.00 value · $72.50 price	+8.4%
5	INTU	Intuit · $97.6B	Seriously undervalued37%	$563.00 value · $357.20 price	−12.9%
6	LMT	Lockheed Martin · $110B	Fairly valued7%	$502.00 value · $468.20 price	−14.2%

86 more names qualify on tonight’s snapshot.

Rank	Ticker	Company	Verdict	Value against price	One year
1	UNHnew	UnitedHealth · $292B	Undervalued22%	$412.00 value · $321.40 price	−36.2%

Names that qualified since the last snapshot. A followed list puts them in Monday’s letter.

No new entrants since the last visit.Tonight's snapshot ranked the same names as the last one.

Win rate61%trailing twelve months, thirty-day holds

Average return per hold+7.4%thirty-day holds

StrategyQuality compoundersgoverned run

Point-in-time data, deflated Sharpe against the number of trials, out-of-sample embargo. The Quant lens on Track record shows the trial ledger. Past performance does not guarantee future results.

Other lists

Most undervalued923 names · The composite value gap, ranked over the universe. The reference list of the scoring pipeline.Undervalued and being bought41 names · A discount to our value and disclosed buying inside thirty days: insiders, funds or politicians.Congress buying27 names · Two or more members purchased inside thirty days, both parties counted, plan sales excluded.

run_id 8f2c1e04-…-a91bmodel dcf@1.9.2 · v418tunables v4vintage 2026-09-02inputs snapshot 2 Sep 2026, strategy run Quality compounders, v418status provisional · previous run shown

Design preview: illustrative figures throughout, invented and tied to no live run and no real company’s accounts. Analysis is not advice and nothing here is a recommendation to buy or sell any security.

Insider, fund and congressional disclosures are shown with the lag between transaction and filing, because that lag is part of what a row means. Valuations are model output under stated conventions, reproducible only from a run’s own recorded inputs, version and vintage.